Appropriate proton pump inhibitor use among older adults: A retrospective chart review

American Journal Geriatric Pharmacotherapy

Volumn 6, Issue 5, 2008, Pages 249-254

  George, Claudene J ^a   Korc, Beatriz ^b   Ross, Joseph S ^b,c  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

outpatient; polypharmacy; proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ESOMEPRAZOLE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; STEROID; WARFARIN;

ABDOMINAL DISCOMFORT; ADULT; AGE DISTRIBUTION; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MONITORING; DRUG USE; DUODENUM ULCER; DYSGEUSIA; FEMALE; FOOD AND DRUG ADMINISTRATION; GASTROESOPHAGEAL REFLUX; GERIATRIC CARE; HELICOBACTER INFECTION; HIATUS HERNIA; HOARSENESS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT CARE; PEPTIC ULCER; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; REFLUX ESOPHAGITIS; SAMPLING; SEX DIFFERENCE; STOMACH ULCER; URBAN AREA; ZOLLINGER ELLISON SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; DRUG UTILIZATION REVIEW; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MEDICAL RECORDS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 58349117710     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2008.12.001     Document Type: Article

References (26)

1. IMS Health, IMS National Sales Perspectives 3/2007. Top 10 therapeutic classes by US sales.
2. http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_80408854_ 80411855,00.html Accessed February 13, 2008
3. Scagliarini R., Magnani E., Praticò A., et al. Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci 50 (2005) 2307-2311
4. Naunton M., Peterson G.M., and Bleasel M.D. Overuse of proton pump inhibitors. J Clin Pharm Ther 25 (2000) 333-340
5. Slattery E., Theyventhiran R., Cullen G., et al. Intravenous proton pump inhibitor use in hospital practice. Eur J Gastroenterol Hepatol 19 (2007) 461-464
6. Afif W., Alsulaiman R., Martel M., and Barkun A.N. Predictors of inappropriate utilization of intravenous proton pump inhibitors. Aliment Pharmacol Ther 25 (2007) 609-615
7. Batuwitage B.T., Kingham J.G., Morgan N.E., and Bartlett R.L. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 83 (2007) 66-68
8. Woodhouse K.W., and O'Mahony M.S. Frailty and ageing. Age Ageing 26 (1997) 245-246
9. Gurwitz J.H., Rochon P., and for the Food and Drug Administration (US). Improving the quality of medication use in elderly patients: A not-so-simple prescription. Arch Intern Med 162 (2002) 1670-1672
10. Simonson W., and Feinberg J.L. Medication-related problems in the elderly: Defining the issues and identifying solutions. Drugs Aging 22 (2005) 559-569
11. Gurwitz J.H. Polypharmacy: A new paradigm for quality drug therapy in the elderly?. Arch Intern Med 164 (2004) 1957-1959
12. Dial S., Delaney J.A., Barkun A.N., and Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
13. Choudhry M.N., Soran H., and Ziglam H.M. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QJM 101 (2008) 445-448
14. Laheij R.J., Sturkenboom M.C., Hassing R.J., et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
15. Yang Y.X., Lewis J.D., Epstein S., and Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296 (2006) 2947-2953
16. Targownik L.E., Lix L.M., Metge C.J., et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 179 (2008) 319-326
17. Ryder S.D., O'Reilly S., Miller R.J., et al. Long term acid suppressing treatment in general practice. BMJ 308 (1994) 827-830
18. Roberts S.J., and Bateman D.N. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England. Aliment Pharmacol Ther 9 (1995) 137-143
19. Boutet R., Wilcock M., and MacKenzie I. Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly. Aliment Pharmacol Ther 13 (1999) 813-817
20. Lassen A., Hallas J., and Schaffalitzky De Muckadell O.B. Use of anti-secretory medication: A population-based cohort study. Aliment Pharmacol Ther 20 (2004) 577-583
21. Lanza F.L., and for the Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 93 (1998) 2037-2046
22. Talley N.J., Vakil N., and for the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 100 (2005) 2324-2337
23. Talley N.J., and for the American Gastroenterological Association. American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology 129 (2005) 1753-1755
24. Nardino R.J., Vender R.J., and Herbert P.N. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 95 (2000) 3118-3122
25. Glew C.M., and Rentler R.J. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc 8 (2007) 607-609
26. Pilotto A., Franceschi M., and Paris F. Recent advances in the treatment of GERD in the elderly: Focus on proton pump inhibitors. Int J Clin Pract 59 (2005) 1204-1209